Printer-friendly: Click to view
  • Summary date: May 6 2024 - View Summary

    Adds new GS 58-3-241 (pertaining to fertility treatment coverage), as follows. Defines experimental fertility procedure, fertility treatment, and insurer. Directs that, if health benefit plan provides fertility treatment coverage then (1) any limitation on coverage for ovulation medication cannot be different than the limits imposed on other prescription medications and (2) no annual or lifetime limits may apply to the coverage for ovulation medication and in-network ovulation induction cycles. Specifies that GS 58-3-241 cannot be construed to required coverage for fertility treatment or experimental fertility procedures under a health benefit plan. Applies to insurance contracts issued, renewed or amended on or after October 1, 2024.  Requires the Board of Trustees for the State Health Plan for Teachers and State Employees to modify the plan’s provisions pertaining to ovulation medication and ovulation induction so that they mirror the provisions set forth above, effective January 1, 2025. 

    Appropriates $2.5 million from the General Fund to the Department of Insurance to implement the coverage provisions for insurance plans that are not the state health plan, including education campaigns directed toward consumers or insurers about the coverage changes, effective July 1, 2024.